Gisoo Barnes

5PUBLICATIONS
7CO-AUTHORS
Cross-sectional analysisMedical molecular engineering of nucleic acids and proteinsEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 21, 2025
Psychometric validation of the EORTC QLQ-OES18 in patients with advanced or metastatic esophageal squamous cell carcinoma.

Lauren Podger, Daniel Serrano, Liyun Li

|Jul 29, 2024
Health-related quality of life in patients with Waldenström macroglobulinemia: results from the ASPEN trial.

Alessandra Tedeschi, Constantine S Tam, Roger G Owen

|Apr 27, 2024
Effects of tislelizumab on health-related quality of life in patients with recurrent or metastatic nasopharyngeal cancer.

Yunpeng Yang, Jianji Pan, Nianyong Chen

|Aug 17, 2023
The effects of tislelizumab treatment on the health-related quality of life of patients with advanced non-small cell lung cancer.

Dingzhi Huang, Caicun Zhou, Gisoo Barnes

|May 02, 2022
Real-World longitudinal practice patterns in the use of PD-1 and PD-L1 inhibitors as First-Line therapy in patients with Non-Small cell lung cancer in the United States.

Rajwanth Veluswamy, Fred R Hirsch, Emanuela Taioli

Pageof 1

Frequent Collaborators

1 joint publications

Rajwanth Veluswamy

1 joint publications

Dingzhi Huang

1 joint publications

Caicun Zhou

1 joint publications

Nianyong Chen